Literature DB >> 12404678

The role of cortisol suppression on craving for and satisfaction from nicotine in high and low impulsive subjects.

M Reuter1, P Netter, A Rogausch, P Sander, M Kaltschmidt, A Dörr, J Hennig.   

Abstract

The rewarding properties of drug self-administration have been shown to depend on mesolimbic dopamine release but also on the availability of corticosterone, as shown in rats. Since this became particularly evident when tested in rat strains bred for high (HR) and low (LR) reactivity to novel stimuli, the role of cortisol and personality in drug craving was investigated in 60 male nicotine-deprived smokers divided according to questionnaire scores into high and low impulsives, a dimension considered to represent HR/LR rats. They either received the peripheral cortisol blocker metyrapone (MET) or the centrally blocking substance dexamethasone (DEX) or placebo (n=20 each) and were then allowed to smoke. MET more than DEX reduced craving for cigarettes during deprivation. This was only observed in low impulsives while high impulsives developed low craving unmodified by blockade of cortisol. Satisfaction from smoking was less achieved with DEX than with MET and not modified by impulsivity. Differences between MET and DEX in influencing craving during deprivation and satisfaction from smoking were discussed on the basis of different glucocorticoid receptors. The mineralocorticoid receptor (MR) seems to be the 'turn on switch' and the glucocorticoid receptor (GR) the 'turn off switch' in mediating the rewarding properties of dopamine in drug self-administration. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12404678     DOI: 10.1002/hup.402

Source DB:  PubMed          Journal:  Hum Psychopharmacol        ISSN: 0885-6222            Impact factor:   1.672


  7 in total

1.  Changes in anxiety after administration of cortisol to rats selected for the ability to acquire active avoidance.

Authors:  E P Vinogradova; D A Zhukov
Journal:  Neurosci Behav Physiol       Date:  2008-09-18

2.  Effects of exercise on the desire to smoke and physiological responses to temporary smoking abstinence: a crossover trial.

Authors:  Vaughan Roberts; Nicholas Gant; John J Sollers; Chris Bullen; Yannan Jiang; Ralph Maddison
Journal:  Psychopharmacology (Berl)       Date:  2014-09-30       Impact factor: 4.530

3.  Associations between adrenocortical activity and nicotine response in female smokers by menstrual phase.

Authors:  Eileen A Huttlin; Alicia M Allen; Nicole L Tosun; Sharon S Allen; Mustafa al'Absi
Journal:  Addict Behav       Date:  2015-06-11       Impact factor: 3.913

4.  FKBP5 variation is associated with the acute and chronic effects of nicotine.

Authors:  K P Jensen; A I Herman; M E Morean; H R Kranzler; J Gelernter; M Sofuoglu
Journal:  Pharmacogenomics J       Date:  2014-12-23       Impact factor: 3.550

5.  A randomised placebo-controlled trial of oral hydrocortisone for treating tobacco withdrawal symptoms.

Authors:  Michael Ussher; Paul Aveyard; Fiona Reid; Robert West; Phil Evans; Angela Clow; Frank Hucklebridge; Julie Fuller; Judith Ibison; Andrew Steptoe
Journal:  Psychopharmacology (Berl)       Date:  2011-02-09       Impact factor: 4.530

6.  Effects of acute psychosocial stress on cigarette craving and smoking.

Authors:  Emma Childs; Harriet de Wit
Journal:  Nicotine Tob Res       Date:  2010-01-25       Impact factor: 4.244

7.  App-Based Mindfulness Training Predicts Reductions in Smoking Behavior by Engaging Reinforcement Learning Mechanisms: A Preliminary Naturalistic Single-Arm Study.

Authors:  Veronique A Taylor; Ryan Smith; Judson A Brewer
Journal:  Sensors (Basel)       Date:  2022-07-08       Impact factor: 3.847

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.